Skip to main content
Caplight Logo









ANEUVO

ANEUVO

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://aneuvo.com/

Last Round

Series C

Mar 5, 2026

Total Funding Raised

$30.37M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

ANEUVO is a medical technology company that develops bioelectronic medicine and non-invasive neuromodulation devices to treat disabling injuries and conditions such as spinal cord injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

neuromodulationspinal cord injurymedical deviceelectrical stimulationrehabilitation technologyneurotechmotor function recoverytranscutaneous stimulationFDA-cleared deviceclinical rehabilitationbioelectronic medicineneural pathwaysassistive technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ANEUVO Comparables

Compare ANEUVO with similar companies based on industry and business-model similarity.

ANEUVO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ONWARD Medical N.V.
87%
SpineX Inc.
84%
Soterix Medical
72%

ANEUVO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 5, 2026
GrantOct 28, 2021
GrantSep 7, 2021
Series AOct 23, 2018
GrantDec 1, 2016

Key People

Founding team and executive leadership

Yi-Kai Lo

Chief Executive Officer

Executive Team

ANEUVO Investors

Notable investors and investment history

ANEUVO investors
InvestorRounds
UCLA Innovation FundGrant
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 33, 2.4x the trailing average.

  • Jul 25, 2026

    Monthly visitors increased 51% MoM.

ANEUVO Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ANEUVO Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ANEUVO's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range30
Year Founded2016
Last FundingMar 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?